Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Long Term Discontinuation Of Eltrombopag After Remission In Primary Immune Thrombocytopenia: 8-Year Follow-Up Data From 15 Spanish Centers

Tomas Jose Gonzalez-Lopez,Fernando Fernandez-Fuertes,Maria Cristina Pascual Izquierdo,Isabel Caparros,Silvia Bernat,Carmen Pastoriza,Maria Paz Martínez-Badas,Pável E Olivera,Gonzalo Caballero,Jose Angel Hernandez-Rivas,Daniel Martínez-Carballeira, Inmaculada Soto Ortega,Gloria Perez Segura, Isabel Regalado,Blanca Sánchez-González,Isidro Jarque,Luis Javier garcia Frade,Miguel A. Sanz

BLOOD（2019）

Cited 1|Views33
No score
Abstract
Background: Successful discontinuation of eltrombopag in certain immune thrombocytopenia (ITP) patients after complete response has already been demonstrated. However, the frequency of this phenomenon and type of candidate patients are still matter of discussion. Moreover, possibility of long term discontinuation responses is not clearly established.
More
Translated text
Key words
primary immune thrombocytopenia,eltrombopag
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined